Introduction
Tumor markers are substances found in the blood that can help diagnose, monitor, and manage testicular cancer. Common markers for testicular cancer include alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH). At Crossroads Urology, testing for these markers is an essential part of diagnosing testicular cancer, assessing treatment response, and monitoring for recurrence.
Purpose
Tumor marker testing is used to:
- Diagnose testicular cancer and identify its subtype (seminoma or non-seminoma).
- Evaluate the extent of the disease and guide treatment planning.
- Monitor treatment effectiveness, such as chemotherapy or surgery.
- Detect recurrence during follow-up care.
Markers and Their Significance
- Alpha-Fetoprotein (AFP):
- Elevated in non-seminomatous germ cell tumors (NSGCTs).
- Not typically elevated in seminomas or pure choriocarcinomas.
- Beta-Human Chorionic Gonadotropin (β-hCG):
- Elevated in both seminomas and NSGCTs, especially choriocarcinomas.
- Lactate Dehydrogenase (LDH):
- A less specific marker, often elevated in advanced disease or significant tumor burden.
Procedure
- A blood sample is drawn from a vein in the arm.
- The sample is analyzed in a laboratory to measure levels of AFP, β-hCG, and LDH.
- Results are typically available within 1-2 days.
Preparation
- No fasting is required for tumor marker testing.
- Inform the provider about any recent illnesses or conditions that may affect the results, such as liver disease or pregnancy in female patients (if applicable).
Risks and Considerations
- Testing is safe, with minor risks associated with blood draws, such as bruising or discomfort.
- Elevated tumor markers should be interpreted in conjunction with imaging studies and clinical findings.
At Crossroads Urology, we ensure thorough evaluation of tumor marker results to guide effective treatment planning.
Results
- Normal Ranges (may vary slightly by laboratory):
- AFP: <10 ng/mL
- β-hCG: <5 mIU/mL
- LDH: 140–280 U/L
- Elevated markers may confirm the presence of testicular cancer or indicate recurrence.
- Persistent or rising levels post-treatment may suggest residual disease or metastasis.
Conclusion
Tumor marker testing is a cornerstone of testicular cancer diagnosis and management. At Crossroads Urology, we combine advanced diagnostics with personalized care to ensure optimal outcomes for our patients. Contact us today to learn more about tumor marker testing and schedule your evaluation.
